New York State Common Retirement Fund’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
AC
CWP
PRTG
YIH
PI
BEAM
CAWM
GIA
IA
New York State Common Retirement Fund's CRDF Position: Q2 2026 in Review
New York State Common Retirement Fund sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 3,600 shares — an estimated $5.83K sold.
New York State Common Retirement Fund first reported a position in CRDF in Q2 2015 and held it in 21 quarters. The position peaked at $205K in Q2 2021. 24 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- New York State Common Retirement Fund reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
- New York State Common Retirement Fund sold 3,600 Cardiff Oncology shares in Q2 2026, an estimated $5.83K.
- New York State Common Retirement Fund first reported a position in Cardiff Oncology in Q2 2015 and held it in 21 quarters.
- New York State Common Retirement Fund's Cardiff Oncology position peaked at $205K in Q2 2021.
- 24 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.